VKTX - Viking Therapeutics, Inc. NasdaqCM - NasdaqCM Real Time 6/30/, 3/31/, 12/31/ Market Cap Stock Price History. Beta (5Y Monthly), The best performance in VKTX stock price from opening price to closing price (referred to as the "drift" for the day) was on Dec for a +% gain. View the latest Viking Therapeutics Inc. (VKTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. VKTX - Viking Therapeutics, Inc. NasdaqCM - NasdaqCM Real Time Price. Currency in USD. Follow. VKTX Earnings History ; Feb 07, , (Q4). / , % () ; Oct 26, , (Q3). / , % ().

The 4 Wall Street analysts offering Viking Therapeutics stock forecast in the last 6 months have average price target of $ with a high forecast of $ VKTX Stock , , (projected). Change In Cash, (M) Unsystematic risk is the risk that events specific to Viking Therapeutics or Biotechnology. Viking Therapeutics (VKTX) Stock Price & Analysis VKTX Stock 12 Months Forecast. All Analysts. Top M M M M 0. Income Statement >. VKTX price forecast details. VKTX (VKTX) forecast & stock price prediction for next days, VKTX future price. VKTX Forecast, Long-Term Price. Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Viking Therapeutics is forecast to grow earnings and revenue by % and 61% per annum respectively while EPS is expected to grow by % per annum. Viking Therapeutics Inc Stock Forecast & Price Prediction ; Revenue for N/A ; Revenue for N/A ; EPS this year N/A ; EPS next year N/A ; The highest. 12/ 09/ 06/ 03/ 12/ $ $ $ $ $ $ Release Date, Actual, Forecast. Apr 24, (03/). EPS. Revenue. -. Viking Therapeutics, Inc. (VKTX): Price and Financial Metrics ; 5-year, % ; YTD, % ; , % ; , % ; , %. Based on a normal probability distribution, the odds of Viking Therapeutics jumping above the current price in 90 days from now is about %. The Viking.

VKTX reached its all-time high on Feb 27, with the price of USD, and its all-time low was USD and was reached on Aug 1, See other stocks. On average, Wall Street analysts predict that Viking Therapeutics's share price could reach $ by Mar 8, The average Viking Therapeutics stock price. The 27 analysts offering price forecasts for Viking Therapeutics have a median target of , with a high estimate of and a low estimate of The. VKTX - Viking Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). Research Viking Therapeutics' (Nasdaq:VKTX) stock price Currently unprofitable and not forecast to to Report Q3, Results on Oct 26, Oct Dec Revenue. Net income. (USD), Dec info. Fiscal Q4 ended 12/31/ Reported on 2/7/ Y/Y change. Revenue. The total amount of income generated. Their VKTX share price targets range from $ to $ On average, they anticipate the company's share price to reach $ in the next twelve months. According to 12 analysts, the average rating for VKTX stock is "Strong Buy." The month stock price forecast is $, which is a decrease of % from the. VKTX stock price and news, along with industry-best analysis 19, p.m. ET. Madrigal Pharmaceuticals Stocks: Real-time U.S. stock quotes reflect.

2/8/, Q4 , ($) ; 10/26/, Q3 , ($) ; newsletter. Get the Latest News and Ratings for VKTX and Related Stocks. Viking Therapeutics (NASDAQ: VKTX). $ (%). $ Price as of March 12, VKTX - Viking Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). A high-level overview of Viking Therapeutics, Inc. (VKTX) stock Latest Stock Analysis. Follow. $ (+ 30, Comments. Bret Jensen profile. Stock VKTX VIKING THERAPEUTICS, INC. PDF Report Q1 Q2 Q3 Q4 Q1 Q2 Oppenheimer Adjusts Viking Therapeutics Price Target to $

games you can earn money on iphone | coin circle app

Copyright 2014-2024 Privice Policy Contacts